Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Kenneth K. Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2156-6164; OpenAlex author ID A5002493916. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 8

  1. Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. Co-author DOI 10.1016/j.jphotobiol.2025.113126↗
  2. EUS-guided verteporfin photodynamic therapy for pancreatic cancer. Last author DOI 10.1016/j.gie.2021.02.027↗
  3. Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D in vitro heterocellular model of pancre… Co-author DOI 10.1515/nanoph-2021-0304↗
  4. Clinical impact of celiac ganglia metastasis upon pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2019.11.003↗
  5. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment. Last author DOI 10.1117/1.jbo.24.11.118001↗
  6. Endoscopic Ultrasound Fine-Needle Aspiration Diagnosis of Synchronous Primary Pancreatic Adenocarcinoma and Effects on Staging and Resectability. Co-author DOI 10.1016/j.cgh.2016.08.009↗
  7. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.gie.2014.12.036↗
  8. Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines. Last author DOI 10.1002/lsm.22073↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tayyaba Hasan · 4 shared papers, 2019–2025 · strength 0.62
  2. Brian W. Pogue · 4 shared papers, 2019–2025 · strength 0.62
  3. Pushpamali De Silva · 2 shared papers, 2021–2025 · strength 0.38
  4. Michael J. Levy · 5 shared papers, 2012–2020 · strength 0.32
  5. Vinay Chandrasekhara · 2 shared papers, 2020–2025 · strength 0.30
  6. Bryan Quilty Spring · 1 shared paper, 2025 · strength 0.22
  7. Mohammad Ahsan Saad · 1 shared paper, 2025 · strength 0.22
  8. Mark D. Topazian · 3 shared papers, 2015–2020 · strength 0.19
  9. Ferga C. Gleeson · 3 shared papers, 2015–2020 · strength 0.19
  10. Suresh T. Chari · 3 shared papers, 2015–2020 · strength 0.19
  11. Shazia Bano · 1 shared paper, 2021 · strength 0.16
  12. Michael L. Kendrick · 2 shared papers, 2017–2020 · strength 0.15
  13. Yuri Hanada · 1 shared paper, 2021 · strength 0.14
  14. Stephen P. Pereira · 1 shared paper, 2021 · strength 0.14
  15. Jingjing Lu · 1 shared paper, 2019 · strength 0.10
  16. Randall K. Pearson · 2 shared papers, 2015–2017 · strength 0.10
  17. Santhi Swaroop Vege · 2 shared papers, 2015–2017 · strength 0.10
  18. Thomas M. Malikowski · 1 shared paper, 2020 · strength 0.09
  19. Naoki Takahashi · 1 shared paper, 2020 · strength 0.09
  20. Steven R. Alberts · 1 shared paper, 2020 · strength 0.09
  21. Robert R. McWilliams · 1 shared paper, 2020 · strength 0.09
  22. Michael B. Farnell · 1 shared paper, 2017 · strength 0.06
  23. Tarun Rustagi · 1 shared paper, 2017 · strength 0.06
  24. Mark Joseph Truty · 1 shared paper, 2017 · strength 0.06
  25. Larissa L. Fujii‐Lau · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.